BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 26951610)

  • 1. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss.
    Scekic-Zahirovic J; Sendscheid O; El Oussini H; Jambeau M; Sun Y; Mersmann S; Wagner M; Dieterlé S; Sinniger J; Dirrig-Grosch S; Drenner K; Birling MC; Qiu J; Zhou Y; Li H; Fu XD; Rouaux C; Shelkovnikova T; Witting A; Ludolph AC; Kiefer F; Storkebaum E; Lagier-Tourenne C; Dupuis L
    EMBO J; 2016 May; 35(10):1077-97. PubMed ID: 26951610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.
    Scekic-Zahirovic J; Oussini HE; Mersmann S; Drenner K; Wagner M; Sun Y; Allmeroth K; Dieterlé S; Sinniger J; Dirrig-Grosch S; René F; Dormann D; Haass C; Ludolph AC; Lagier-Tourenne C; Storkebaum E; Dupuis L
    Acta Neuropathol; 2017 Jun; 133(6):887-906. PubMed ID: 28243725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
    Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
    Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function.
    Sharma A; Lyashchenko AK; Lu L; Nasrabady SE; Elmaleh M; Mendelsohn M; Nemes A; Tapia JC; Mentis GZ; Shneider NA
    Nat Commun; 2016 Feb; 7():10465. PubMed ID: 26842965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha.
    Kia A; McAvoy K; Krishnamurthy K; Trotti D; Pasinelli P
    Glia; 2018 May; 66(5):1016-1033. PubMed ID: 29380416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
    Wächter N; Storch A; Hermann A
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways.
    Blokhuis AM; Koppers M; Groen EJN; van den Heuvel DMA; Dini Modigliani S; Anink JJ; Fumoto K; van Diggelen F; Snelting A; Sodaar P; Verheijen BM; Demmers JAA; Veldink JH; Aronica E; Bozzoni I; den Hertog J; van den Berg LH; Pasterkamp RJ
    Acta Neuropathol; 2016 Aug; 132(2):175-196. PubMed ID: 27164932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish.
    Yu Y; Chi B; Xia W; Gangopadhyay J; Yamazaki T; Winkelbauer-Hurt ME; Yin S; Eliasse Y; Adams E; Shaw CE; Reed R
    Nucleic Acids Res; 2015 Mar; 43(6):3208-18. PubMed ID: 25735748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice.
    Shelkovnikova TA; Peters OM; Deykin AV; Connor-Robson N; Robinson H; Ustyugov AA; Bachurin SO; Ermolkevich TG; Goldman IL; Sadchikova ER; Kovrazhkina EA; Skvortsova VI; Ling SC; Da Cruz S; Parone PA; Buchman VL; Ninkina NN
    J Biol Chem; 2013 Aug; 288(35):25266-25274. PubMed ID: 23867462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular regression precedes motor neuron loss in the FUS (1-359) ALS mouse model.
    Crivello M; Hogg MC; Jirström E; Halang L; Woods I; Rayner M; Coughlan KS; Lewandowski SA; Prehn JHM
    Dis Model Mech; 2019 Aug; 12(8):. PubMed ID: 31383794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of chromatin remodelling complexes in amyotrophic lateral sclerosis.
    Tibshirani M; Zhao B; Gentil BJ; Minotti S; Marques C; Keith J; Rogaeva E; Zinman L; Rouaux C; Robertson J; Durham HD
    Hum Mol Genet; 2017 Nov; 26(21):4142-4152. PubMed ID: 28973294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic FUS triggers early behavioral alterations linked to cortical neuronal hyperactivity and inhibitory synaptic defects.
    Scekic-Zahirovic J; Sanjuan-Ruiz I; Kan V; Megat S; De Rossi P; Dieterlé S; Cassel R; Jamet M; Kessler P; Wiesner D; Tzeplaeff L; Demais V; Sahadevan S; Hembach KM; Muller HP; Picchiarelli G; Mishra N; Antonucci S; Dirrig-Grosch S; Kassubek J; Rasche V; Ludolph A; Boutillier AL; Roselli F; Polymenidou M; Lagier-Tourenne C; Liebscher S; Dupuis L
    Nat Commun; 2021 May; 12(1):3028. PubMed ID: 34021132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial abnormalities and disruption of the neuromuscular junction precede the clinical phenotype and motor neuron loss in hFUSWT transgenic mice.
    So E; Mitchell JC; Memmi C; Chennell G; Vizcay-Barrena G; Allison L; Shaw CE; Vance C
    Hum Mol Genet; 2018 Feb; 27(3):463-474. PubMed ID: 29194538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations.
    Tradewell ML; Yu Z; Tibshirani M; Boulanger MC; Durham HD; Richard S
    Hum Mol Genet; 2012 Jan; 21(1):136-49. PubMed ID: 21965298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice.
    Shiihashi G; Ito D; Yagi T; Nihei Y; Ebine T; Suzuki N
    Brain; 2016 Sep; 139(Pt 9):2380-94. PubMed ID: 27368346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules.
    Vance C; Scotter EL; Nishimura AL; Troakes C; Mitchell JC; Kathe C; Urwin H; Manser C; Miller CC; Hortobágyi T; Dragunow M; Rogelj B; Shaw CE
    Hum Mol Genet; 2013 Jul; 22(13):2676-88. PubMed ID: 23474818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN.
    Groen EJ; Fumoto K; Blokhuis AM; Engelen-Lee J; Zhou Y; van den Heuvel DM; Koppers M; van Diggelen F; van Heest J; Demmers JA; Kirby J; Shaw PJ; Aronica E; Spliet WG; Veldink JH; van den Berg LH; Pasterkamp RJ
    Hum Mol Genet; 2013 Sep; 22(18):3690-704. PubMed ID: 23681068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion.
    Mitchell JC; McGoldrick P; Vance C; Hortobagyi T; Sreedharan J; Rogelj B; Tudor EL; Smith BN; Klasen C; Miller CC; Cooper JD; Greensmith L; Shaw CE
    Acta Neuropathol; 2013 Feb; 125(2):273-88. PubMed ID: 22961620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear import factor transportin and arginine methyltransferase 1 modify FUS neurotoxicity in Drosophila.
    Jäckel S; Summerer AK; Thömmes CM; Pan X; Voigt A; Schulz JB; Rasse TM; Dormann D; Haass C; Kahle PJ
    Neurobiol Dis; 2015 Feb; 74():76-88. PubMed ID: 25447237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in 'FUSDelta14' knockin mice.
    Devoy A; Kalmar B; Stewart M; Park H; Burke B; Noy SJ; Redhead Y; Humphrey J; Lo K; Jaeger J; Mejia Maza A; Sivakumar P; Bertolin C; Soraru G; Plagnol V; Greensmith L; Acevedo Arozena A; Isaacs AM; Davies B; Fratta P; Fisher EMC
    Brain; 2017 Nov; 140(11):2797-2805. PubMed ID: 29053787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.